• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH UNK - BIOMATERIAL - CEMENT: VERTECEM V+; CEMENT, BONE, VERTEBROPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH UNK - BIOMATERIAL - CEMENT: VERTECEM V+; CEMENT, BONE, VERTEBROPLASTY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Necrosis (1971); Osteolysis (2377)
Event Type  Injury  
Manufacturer Narrative
This report is for an unknown polymethylmethacrylate (pmma) cement (vertecem v+)/unknown lot.Part and lot number are unknown.Without the specific part number; the udi number and 510-k number is unknown.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This report is being filed after the review of a clinical evaluation report (cer) from a related research activity database (ddra) for 78 patients with 26 females and 52 males (mean age, 61 ± 14 [21 - 90] years; 66.7% female) undergoing vbs procedures for traumatic, osteoporotic, or metastatic thoracolumbar compression fractures between 01/2012 and 12/2020 were included in the study.Minimum follow-up period was 6 months after surgery.Polymethylmethacrylate (pmma) cement (vertecem v+, depuy synthes, raynham, ma, usa) was injected bilaterally into the stent cavities.Complications: intraoperative complications - (material failure (n=2) therein no stent deployment could be seen.(n=2) insufficient ballooning (was defined as a bursted balloon or leaking contrast.Agent despite compliance with the maximum permitted filling volume and pressure.).Radiographic complications - vbs dislocation or cut out.(n=3) cut out.(any stent laying at any part outside of the vertebral cortical border was taken into account for a stent-cut-out).Radiographic complications - cement leakage - no vascular leakage reported -33 (none of the cement leakages had a clinically relevant consequence requiring further treatment.) (n=21) patients with cement leakage into the anterolateral, paravertebral region.-(n=11) patients with intradiscal cement leakage.-(n=1) patient with posterior cement leakage into the spinal canal.Radiographic complications (n=1) adjacent segment fracture.Clinical complications -revision surgery.(n=1) revision surgery.The patient developed potential procedure related spondylodiscitis with subsequent bone necrosis at the vbs level 5 months after index surgery.Therefore, a subtotal corporectomy with cage replacement, disc biopsy and posterior instrumentation was performed.This is for depuy synthes polymethylmethacrylate (pmma) cement (vertecem v+).This report captures the reported adjacent segment fracture and the patient who developed potential procedure related spondylodiscitis with subsequent bone necrosis at the vbs level 5 months -after index surgery.Therefore, a subtotal corporectomy with cage replacement, disc biopsy and posterior instrumentation was performed.This is report 3 of 6 for pc-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - BIOMATERIAL - CEMENT: VERTECEM V+
Type of Device
CEMENT, BONE, VERTEBROPLASTY
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
Manufacturer Contact
kate karberg
1302 wrights lane east
west chester, PA 19380
8472871282
MDR Report Key14641106
MDR Text Key294859210
Report Number8030965-2022-03822
Device Sequence Number1
Product Code NDN
Combination Product (y/n)N
Reporter Country CodeSZ
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-